MAPAKNA LP 20 mg, extended-release tablet 10 tablets
Active ingredients: Nifedipine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Extended-release film-coated tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MAPAKNA LP 20 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES MAJORELLE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Apr 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61545442CIP75509241CIP133400955092414Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NIFÉDIPINEcomprimé | 20,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.